The FDA is requiring that a medication guide about treatment with naltrexone extended-release injectable suspension be provided to all patients.
FDA正在要求制订一份可提供给所有患者的有关使用纳曲酮缓释注射用混悬剂治疗的用药指南。
Naltrexone extended-release injectable suspension is the first — and currently the only — once-monthly injectable medication for alcohol dependence.
纳曲酮缓释注射用混悬剂是首个也是目前仅有的每月注射一次用于治疗酒精依赖的药物。
Naltrexone extended-release injectable suspension is the first — and currently the only — once-monthly injectable medication for alcohol dependence.
纳曲酮缓释注射用混悬剂是首个也是目前仅有的每月注射一次用于治疗酒精依赖的药物。
应用推荐